United States Food and Drug Administration (USFDA) has concluded inspection at Zydus group’s injectables manufacturing facility at Zydus Biotech Park, in Changodar, Ahmedabad from June 5, 2023 to June 13, 2023. The cGMP inspection concluded with NIL observations.
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.